Oramed Pharmaceuticals (Israel) Probability of Future Stock Price Finishing Over 8.63
| ORMP Stock | 8.63 0.02 0.23% |
Oramed |
Oramed Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Oramed Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Oramed Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Oramed Pharmaceuticals generated a negative expected return over the last 90 days | |
| Oramed Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 2.64 M. Net Loss for the year was (15 M) with profit before overhead, payroll, taxes, and interest of 2.54 M. | |
| Oramed Pharmaceuticals has accumulated about 26.19 M in cash with (14.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.51. |
Oramed Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Oramed Stock often depends not only on the future outlook of the current and potential Oramed Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Oramed Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Float Shares | 14.48M |
Oramed Pharmaceuticals Technical Analysis
Oramed Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Oramed Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Oramed Pharmaceuticals. In general, you should focus on analyzing Oramed Stock price patterns and their correlations with different microeconomic environments and drivers.
Oramed Pharmaceuticals Predictive Forecast Models
Oramed Pharmaceuticals' time-series forecasting models is one of many Oramed Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Oramed Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Oramed Pharmaceuticals
Checking the ongoing alerts about Oramed Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Oramed Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Oramed Pharmaceuticals generated a negative expected return over the last 90 days | |
| Oramed Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 2.64 M. Net Loss for the year was (15 M) with profit before overhead, payroll, taxes, and interest of 2.54 M. | |
| Oramed Pharmaceuticals has accumulated about 26.19 M in cash with (14.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.51. |
Additional Information and Resources on Investing in Oramed Stock
When determining whether Oramed Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Oramed Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Oramed Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Oramed Pharmaceuticals Stock:Check out Oramed Pharmaceuticals Backtesting, Oramed Pharmaceuticals Valuation, Oramed Pharmaceuticals Correlation, Oramed Pharmaceuticals Hype Analysis, Oramed Pharmaceuticals Volatility, Oramed Pharmaceuticals History as well as Oramed Pharmaceuticals Performance. For information on how to trade Oramed Stock refer to our How to Trade Oramed Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.